ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OCR

97.90
0.00 (0.00%)
31 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
NYSE:OCR NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 97.90 0.00 00:00:00

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Omnicare, Inc.

27/05/2015 10:35am

Business Wire


Omnicare (NYSE:OCR)
Historical Stock Chart


From Feb 2020 to Feb 2025

Click Here for more Omnicare Charts.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Omnicare, Inc. ("Omnicare” or "the Company") (NYSE: OCR) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to CVS Health Corporation, Inc. (“CVS”).

Click here to learn more about the investigation http://brodsky-smith.com/941-ocr-omnicare-inc.html, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, Omnicare shareholders will receive only $98.00 in cash for each share of Omnicare stock they own. The investigation concerns whether the Board of Omnicare breached their fiduciary duties to shareholders and whether CVS is underpaying for Omnicare. The transaction may undervalue Omnicare as the Company has had 20% annual increases in revenue from its specialty unit, which provides services that support drug makers, distributors and health professionals who care for patients with complex diseases. Thereby, allowing CVS to expand significantly in the assisted-living market, which is expected to grow markedly. In addition, an analyst has placed a $104.00 per share price target on Omnicare stock.

If you own shares of Omnicare and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://brodsky-smith.com/941-ocr-omnicare-inc.html, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

Brodsky & Smith, LLCJason L. Brodsky, EsquireEvan J. Smith, Esquire877-LEGAL-90http://brodsky-smith.com/941-ocr-omnicare-inc.html

1 Year Omnicare Chart

1 Year Omnicare Chart

1 Month Omnicare Chart

1 Month Omnicare Chart